A detailed history of Fruth Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Fruth Investment Management holds 31,466 shares of ABT stock, worth $3.58 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
31,466
Previous 32,437 2.99%
Holding current value
$3.58 Million
Previous $3.69 Million 11.31%
% of portfolio
0.89%
Previous 0.95%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $97,808 - $109,179
-971 Reduced 2.99%
31,466 $3.27 Million
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $28,475 - $31,449
-260 Reduced 0.8%
32,437 $3.69 Million
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $12,705 - $15,244
-133 Reduced 0.41%
32,697 $3.17 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $403 - $449
-4 Reduced 0.01%
32,830 $3.58 Million
Q1 2023

Apr 26, 2023

SELL
$96.86 - $114.01 $678 - $798
-7 Reduced 0.02%
32,834 $3.32 Million
Q4 2022

Jan 17, 2023

SELL
$95.06 - $111.52 $23,765 - $27,880
-250 Reduced 0.76%
32,841 $3.61 Million
Q3 2022

Oct 13, 2022

SELL
$96.76 - $112.03 $31,930 - $36,969
-330 Reduced 0.99%
33,091 $3.2 Million
Q2 2022

Jul 19, 2022

SELL
$102.07 - $123.37 $22,455 - $27,141
-220 Reduced 0.65%
33,421 $4.02 Million
Q1 2022

Apr 12, 2022

SELL
$114.02 - $139.04 $6,271 - $7,647
-55 Reduced 0.16%
33,641 $3.98 Million
Q4 2021

Jan 14, 2022

SELL
$115.53 - $141.46 $5,314 - $6,507
-46 Reduced 0.14%
33,696 $4.74 Million
Q3 2021

Oct 12, 2021

SELL
$116.66 - $129.06 $14,582 - $16,132
-125 Reduced 0.37%
33,742 $3.99 Million
Q1 2021

Apr 14, 2021

SELL
$108.84 - $128.23 $47,889 - $56,421
-440 Reduced 1.28%
33,867 $4.06 Million
Q4 2020

Jan 13, 2021

SELL
$105.0 - $114.42 $94,500 - $102,978
-900 Reduced 2.56%
34,307 $3.76 Million
Q3 2020

Oct 07, 2020

SELL
$91.64 - $111.29 $73,312 - $89,032
-800 Reduced 2.22%
35,207 $3.83 Million
Q2 2020

Jul 13, 2020

BUY
$76.57 - $98.0 $34,456 - $44,100
450 Added 1.27%
36,007 $3.29 Million
Q1 2020

Apr 29, 2020

BUY
$62.82 - $91.86 $34,739 - $50,798
553 Added 1.58%
35,557 $2.81 Million
Q4 2019

Jan 10, 2020

SELL
$78.51 - $87.4 $50,481 - $56,198
-643 Reduced 1.8%
35,004 $3.04 Million
Q3 2019

Oct 09, 2019

SELL
$81.84 - $88.74 $8,184 - $8,874
-100 Reduced 0.28%
35,647 $2.98 Million
Q2 2019

Jul 15, 2019

SELL
$72.88 - $85.0 $1,822 - $2,125
-25 Reduced 0.07%
35,747 $3.01 Million
Q1 2019

Apr 16, 2019

SELL
$66.22 - $80.06 $79,464 - $96,072
-1,200 Reduced 3.25%
35,772 $2.86 Million
Q4 2018

Jan 16, 2019

SELL
$65.56 - $74.27 $32,780 - $37,135
-500 Reduced 1.33%
36,972 $2.67 Million
Q3 2018

Oct 10, 2018

SELL
$60.81 - $73.36 $6,081 - $7,336
-100 Reduced 0.27%
37,472 $2.75 Million
Q1 2018

May 01, 2018

SELL
$56.27 - $63.62 $74,782 - $84,550
-1,329 Reduced 3.42%
37,572 $2.25 Million
Q4 2017

Jan 09, 2018

SELL
$53.68 - $57.47 $60,658 - $64,941
-1,130 Reduced 2.82%
38,901 $2.22 Million
Q3 2017

Oct 12, 2017

BUY
$48.06 - $53.64 $1.92 Million - $2.15 Million
40,031
40,031 $2.14 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fruth Investment Management Portfolio

Follow Fruth Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fruth Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Fruth Investment Management with notifications on news.